🎉 M&A multiples are live!
Check it out!

Comvita Valuation Multiples

Discover revenue and EBITDA valuation multiples for Comvita and similar public comparables like Sarantis Group, Lavipharm, and EZZ Life Science.

Comvita Overview

About Comvita

Comvita Ltd is a New Zealand based company. It is engaged in the development and marketing of natural health and wellbeing products. Its products include manuka honey, manuka honey extract, nutritional oils, royal jelly, olive leaf extract, and other products. The company's geographical segments include Greater China; ANZ; Rest of Asia; North America and EMEA. It derives a majority of its revenue from Greater China.


Founded

1974

HQ

New Zealand
Employees

577

Website

comvita.co.nz

Sectors

Health & Beauty

Financials

LTM Revenue $115M

LTM EBITDA -$6.4M

EV

$112M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Comvita Financials

As of August 2025, Comvita reported last 12-month revenue of $115M and EBITDA of -$6.4M.

In the same period, Comvita generated $51.8M in LTM gross profit and -$48.0M in net income.

See Comvita valuation multiples based on analyst estimates

Comvita P&L

In the most recent fiscal year, Comvita reported revenue of $120M and EBITDA of -$35.3M.

Comvita expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Comvita valuation multiples based on analyst estimates
LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $115M XXX $120M XXX XXX XXX
Gross Profit $51.8M XXX $66.4M XXX XXX XXX
Gross Margin 45% XXX 55% XXX XXX XXX
EBITDA -$6.4M XXX -$35.3M XXX XXX XXX
EBITDA Margin -6% XXX -29% XXX XXX XXX
EBIT -$38.9M XXX -$15.2M XXX XXX XXX
EBIT Margin -34% XXX -13% XXX XXX XXX
Net Profit -$48.0M XXX -$45.6M XXX XXX XXX
Net Margin -42% XXX -38% XXX XXX XXX
Net Debt XXX XXX $46.9M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Comvita Stock Performance

Comvita has current market cap of NZD 107M (or $63.1M), and EV of NZD 190M (or $112M).

Market Cap Evolution

Comvita Stock Data

As of September 19, 2025, Comvita's stock price is NZD 2 (or $1).

See Comvita trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$112M $63.1M XXX XXX XXX XXX $-0.32

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Comvita Valuation Multiples

Comvita's trades at 0.9x EV/Revenue multiple, and -15.6x EV/EBITDA.

See valuation multiples for Comvita and 15K+ public comps

Comvita Financial Valuation Multiples

As of September 19, 2025, Comvita has market cap of $63.1M and EV of $112M.

Equity research analysts estimate Comvita's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Comvita has a P/E ratio of -1.3x.

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $63.1M XXX $63.1M XXX XXX XXX
EV (current) $112M XXX $112M XXX XXX XXX
EV/Revenue 1.0x XXX 0.9x XXX XXX XXX
EV/EBITDA -17.5x XXX -15.6x XXX XXX XXX
EV/EBIT -2.9x XXX -14.6x XXX XXX XXX
EV/Gross Profit 2.2x XXX n/a XXX XXX XXX
P/E -1.3x XXX -3.2x XXX XXX XXX
EV/FCF 13.5x XXX -22.7x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Comvita Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Comvita Margins & Growth Rates

Comvita's last 12 month revenue growth is 5%

Comvita's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Comvita's rule of 40 is 0% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Comvita's rule of X is 7% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Comvita and other 15K+ public comps

Comvita Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 5% XXX -3% XXX XXX XXX
EBITDA Margin -6% XXX -6% XXX XXX XXX
EBITDA Growth -212% XXX n/a XXX XXX XXX
Rule of 40 0% XXX 0% XXX XXX XXX
Bessemer Rule of X XXX XXX 7% XXX XXX XXX
Revenue per Employee XXX XXX $0.2M XXX XXX XXX
Opex per Employee XXX XXX $0.1M XXX XXX XXX
S&M Expenses to Revenue XXX XXX 41% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX n/a XXX XXX XXX
Opex to Revenue XXX XXX 68% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Comvita Public Comps

See public comps and valuation multiples for Health & Beauty comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Acme United XXX XXX XXX XXX XXX XXX
EZZ Life Science XXX XXX XXX XXX XXX XXX
Lavipharm XXX XXX XXX XXX XXX XXX
Sarantis Group XXX XXX XXX XXX XXX XXX
SynBiotic XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Comvita M&A and Investment Activity

Comvita acquired  XXX companies to date.

Last acquisition by Comvita was  XXXXXXXX, XXXXX XXXXX XXXXXX . Comvita acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Comvita

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About Comvita

When was Comvita founded? Comvita was founded in 1974.
Where is Comvita headquartered? Comvita is headquartered in New Zealand.
How many employees does Comvita have? As of today, Comvita has 577 employees.
Is Comvita publicy listed? Yes, Comvita is a public company listed on NZE.
What is the stock symbol of Comvita? Comvita trades under CVT ticker.
When did Comvita go public? Comvita went public in 2003.
Who are competitors of Comvita? Similar companies to Comvita include e.g. Acme United, EZZ Life Science, Lavipharm, Sarantis Group.
What is the current market cap of Comvita? Comvita's current market cap is $63.1M
What is the current revenue of Comvita? Comvita's last 12 months revenue is $115M.
What is the current revenue growth of Comvita? Comvita revenue growth (NTM/LTM) is 5%.
What is the current EV/Revenue multiple of Comvita? Current revenue multiple of Comvita is 1.0x.
Is Comvita profitable? Yes, Comvita is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Comvita? Comvita's last 12 months EBITDA is -$6.4M.
What is Comvita's EBITDA margin? Comvita's last 12 months EBITDA margin is -6%.
What is the current EV/EBITDA multiple of Comvita? Current EBITDA multiple of Comvita is -17.5x.
What is the current FCF of Comvita? Comvita's last 12 months FCF is $8.3M.
What is Comvita's FCF margin? Comvita's last 12 months FCF margin is 7%.
What is the current EV/FCF multiple of Comvita? Current FCF multiple of Comvita is 13.5x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.